{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:52Z","timestamp":1791409912462,"version":"4.3.3"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110297","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:13:55Z","timestamp":1785071635000},"page":"110297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sodium ion channels as therapeutic targets in epilepsy: a drug discovery perspective"],"prefix":"10.1016","volume":"181","author":[{"given":"Weizheng","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangju","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2026.110297_bb0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.0b013e318204a36a","article-title":"Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota","volume":"76","author":"Hesdorffer","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bioorg.2026.110297_bb0015","series-title":"World Health Statistics 2025: Monitoring Health for the SDGs","author":"World Health Organization","year":"2025"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJM200108023450501","article-title":"Effectiveness and efficiency of surgery for temporal lobe epilepsy study group. A randomized, controlled trial of surgery for temporal-lobe epilepsy","volume":"345","author":"Wiebe","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"10056","key":"10.1016\/j.bioorg.2026.110297_bb0035","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive Everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110297_bb0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/74159","article-title":"Mutations of SCN1A, encoding a neuronal Sodium Channel, in two families with GEFS+2","volume":"24","author":"Escayg","year":"2000","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110297_bb0045","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"Novo mutations in the Sodium-Channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110297_bb0050","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1073\/pnas.111065098","article-title":"A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures Causes Channel dysfunction","volume":"98","author":"Sugawara","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110297_bb0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ana.25188","article-title":"Mutations in SCN3A cause early infantile epileptic encephalopathy","volume":"83","author":"Zaman","year":"2018","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ajhg.2012.01.006","article-title":"Novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP","volume":"90","author":"Veeramah","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1528-1157.1998.tb01413.x","article-title":"Lamotrigine and seizure aggravation in severe myoclonic epilepsy","volume":"39","author":"Guerrini","year":"1998","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0070","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0021-9258(17)43460-0","article-title":"The Sodium Channel from rat brain. Purification and subunit composition","volume":"259","author":"Hartshorne","year":"1984","journal-title":"J. Biol. Chem."},{"issue":"5990","key":"10.1016\/j.bioorg.2026.110297_bb0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/312121a0","article-title":"Primary structure of electrophorus Electricus Sodium Channel deduced from cDNA sequence","volume":"312","author":"Noda","year":"1984","journal-title":"Nature"},{"issue":"6226","key":"10.1016\/j.bioorg.2026.110297_bb0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/339597a0","article-title":"Structural parts involved in activation and inactivation of the Sodium Channel","volume":"339","author":"St\u00fchmer","year":"1989","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110297_bb0085","doi-asserted-by":"crossref","first-page":"10910","DOI":"10.1073\/pnas.89.22.10910","article-title":"A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation","volume":"89","author":"West","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0090","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220578120","article-title":"Cryo-EM structure of human voltage-gated Sodium Channel Nav1.6","volume":"120","author":"Fan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110297_bb0095","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1523\/JNEUROSCI.5270-06.2007","article-title":"Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation","volume":"27","author":"Ogiwara","year":"2007","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110297_bb0100","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nn.2359","article-title":"Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation","volume":"12","author":"Hu","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"7121","key":"10.1016\/j.bioorg.2026.110297_bb0105","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cell.2019.11.041","article-title":"Structure of the cardiac Sodium Channel","volume":"180","author":"Jiang","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110297_bb0115","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy","volume":"9","author":"Yu","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.biopsych.2017.01.009","article-title":"Opposing effects on NaV1.2 function underlie differences between SCN2A variants observed in individuals with autism Spectrum disorder or infantile seizures","volume":"82","author":"Ben-Shalom","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"17","key":"10.1016\/j.bioorg.2026.110297_bb0125","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1073\/pnas.93.17.9270","article-title":"Common molecular determinants of local Anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels","volume":"93","author":"Ragsdale","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.107.039867","article-title":"The investigational anticonvulsant Lacosamide selectively enhances slow inactivation of voltage-gated sodium channels","volume":"73","author":"Errington","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1474-4422(19)30399-0","article-title":"Safety and efficacy of adjunctive Cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial","volume":"19","author":"Krauss","year":"2020","journal-title":"Lancet Neurol."},{"issue":"41","key":"10.1016\/j.bioorg.2026.110297_bb0140","doi-asserted-by":"crossref","first-page":"11065","DOI":"10.1523\/JNEUROSCI.2162-07.2007","article-title":"Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for Ataxia in severe myoclonic epilepsy in infancy","volume":"27","author":"Kalume","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)81133-2","article-title":"From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels","volume":"26","author":"Catterall","year":"2000","journal-title":"Neuron"},{"issue":"46","key":"10.1016\/j.bioorg.2026.110297_bb0150","doi-asserted-by":"crossref","first-page":"11768","DOI":"10.1523\/JNEUROSCI.3901-08.2008","article-title":"Inherited neuronal ion channelopathies: new windows on complex neurological diseases","volume":"28","author":"Catterall","year":"2008","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110297_bb0155","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1073\/pnas.0813330106","article-title":"Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy","volume":"106","author":"Oakley","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.03.025","article-title":"Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans","volume":"610","author":"L\u00f6scher","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110297_bb0165","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1535-7511.2009.01298.x","article-title":"Adopting an orphan drug: rufinamide for Lennox-Gastaut syndrome","volume":"9","author":"Herman","year":"2009","journal-title":"Epilepsy Curr."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0175","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/cb500108p","article-title":"Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents","volume":"9","author":"Gilchrist","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110297_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128946","article-title":"Discovery of Triazenyl triazoles as Nav1.1 channel blockers for treatment of epilepsy","volume":"75","author":"Zhou","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110297_bb0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100066118","article-title":"Comparative structural analysis of human Nav1.1 and Nav1.5 reveals mutational hotspots for sodium channelopathies","volume":"118","author":"Pan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110297_bb0190","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.bmcl.2018.03.015","article-title":"Design, synthesis, biological evaluation, homology Modeling and docking studies of (E)-3-(benzo[d][1,3]Dioxol-5-Ylmethylene) Pyrrolidin-2-one derivatives as potent anticonvulsant agents","volume":"28","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110297_bb0195","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/acschemneuro.1c00846","article-title":"Design, synthesis, and evaluation of novel benzo[d]isoxazole derivatives as anticonvulsants by selectively blocking the voltage-gated Sodium Channel NaV1.1","volume":"13","author":"Huang","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tips.2013.12.007","article-title":"Therapeutic potential of Na(V)1.1 activators","volume":"35","author":"Jensen","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110297_bb0205","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/acschemneuro.5b00147","article-title":"Identification and electrophysiological evaluation of 2-Methylbenzamide derivatives as Nav1.1 modulators","volume":"6","author":"Crestey","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0210","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/ejn.13626","article-title":"A small molecule activator of nav 1.1 channels increases fast-spiking interneuron excitability and GABAergic transmission in vitro and has anti-convulsive effects in vivo","volume":"46","author":"Frederiksen","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110297_bb0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2017.10.004","article-title":"The Sodium Channel activator Lu AE98134 normalizes the altered firing properties of fast spiking interneurons in Dlx5\/6+\/\u2212 mice","volume":"662","author":"von Schoubye","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110297_bb0220","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.bmcl.2019.01.023","article-title":"Discovery of novel 4-Phenyl-2-(pyrrolidinyl)nicotinamide derivatives as potent Nav1.1 activators","volume":"29","author":"Miyazaki","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110297_bb0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fnmol.2019.00145","article-title":"Scn2a haploinsufficiency in mice suppresses hippocampal neuronal excitability, excitatory synaptic drive, and long-term potentiation, and spatial learning and memory","volume":"12","author":"Shin","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110297_bb0230","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tins.2018.03.011","article-title":"Progress in understanding and treating SCN2A-mediated disorders","volume":"41","author":"Sanders","year":"2018","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0235","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1152\/jn.00309.2021","article-title":"SCN2A-related epilepsy of infancy with migrating focal seizures: report of a variant with apparent gain- and loss-of-function effects","volume":"127","author":"Yang","year":"2022","journal-title":"J. Neurophysiol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110297_bb0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000448369","article-title":"Gene panel testing in epileptic encephalopathies and familial epilepsies","volume":"7","author":"M\u00f8ller","year":"2016","journal-title":"Mol. Syndromol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0245","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cell.2019.12.036","article-title":"Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism","volume":"180","author":"Satterstrom","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0250","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/brain\/awx054","article-title":"Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders","volume":"140","author":"Wolff","year":"2017","journal-title":"Brain"},{"issue":"16","key":"10.1016\/j.bioorg.2026.110297_bb0255","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.0b013e3181f8812e","article-title":"SCN2A mutation associated with neonatal epilepsy, late-onset episodic Ataxia, myoclonus, and pain","volume":"75","author":"Liao","year":"2010","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110297_bb0260","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.bmc.2009.03.067","article-title":"2,4(5)-Diarylimidazoles as inhibitors of hNaV1.2 sodium channels: pharmacological evaluation and structure-property relationships","volume":"17","author":"Fantini","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110297_bb0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmech.2013.05.011","article-title":"Synthesis and biological properties of new N-Mannich bases derived from 3-Methyl-3-phenyl- and 3,3-dimethyl-succinimides. Part V","volume":"66","author":"Kami\u0144ski","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"7826","key":"10.1016\/j.bioorg.2026.110297_bb0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(73)92270-8","article-title":"Treatment of ventricular arrhythmias with mexiletine (K\u00f6 1173)","volume":"2","author":"Talbot","year":"1973","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.bioorg.2026.110297_bb0275","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jama.2012.12607","article-title":"Consortium for clinical investigation of neurologic channelopathies. Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial","volume":"308","author":"Statland","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0280","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cmdc.201800781","article-title":"Discovery of N-Aryloxypropylbenzylamines as voltage-gated Sodium Channel NaV 1.2-subtype-selective inhibitors","volume":"14","author":"van der Peet","year":"2019","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0285","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s43440-023-00477-1","article-title":"Inhibitory effect of atomoxetine on Nav1.2 voltage-gated Sodium Channel currents","volume":"75","author":"Nakatani","year":"2023","journal-title":"Pharmacol. Rep."},{"issue":"22","key":"10.1016\/j.bioorg.2026.110297_bb0290","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1021\/jm400894u","article-title":"Novel, broad-Spectrum anticonvulsants containing a Sulfamide group: pharmacological properties of (S)-N-[(6-Chloro-2,3-dihydrobenzo[1,4]Dioxin-2-Yl)methyl]Sulfamide (JNJ-26489112)","volume":"56","author":"McComsey","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110297_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2017.12.036","article-title":"Antiallodynic and Antihyperalgesic activity of new 3,3-diphenyl-propionamides with anticonvulsant activity in models of pain in mice","volume":"821","author":"Rapacz","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110297_bb0300","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1021\/acs.jmedchem.4c00861","article-title":"Discovery of novel pyrimidine-based derivatives as Nav1.2 inhibitors with efficacy in mouse models of epilepsy","volume":"67","author":"He","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110297_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111824","article-title":"Discovery of [1,2,4]-triazolo [1,5-a]Pyrimidine-7(4H)-one derivatives as positive modulators of GABAA1 receptor with potent anticonvulsant activity and low toxicity","volume":"185","author":"Huang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110297_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105565","article-title":"Discovery of 7-alkyloxy- [1,2,4] triazolo[1,5-a] pyrimidine derivatives as selective positive modulators of GABAA1 and GABAA4 receptors with potent antiepileptic activity","volume":"119","author":"Wu","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110297_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117316","article-title":"Design, synthesis and structure-activity relationship of novel 1,2,4-triazolopyrimidin-5-one derivatives targeting GABAA1 and Nav1.2 with antiepileptic activity","volume":"286","author":"Du","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110297_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106430","article-title":"Design, synthesis, anticonvulsant activity and structure-activity relationships of novel 7-azaindole derivatives","volume":"133","author":"Meng","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110297_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117664","article-title":"Discovery of novel 4-azaindole derivatives as selective Nav1.2 inhibitor with potent antiepileptic activity and low neurotoxicity","volume":"292","author":"Lou","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0330","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0378-1119(00)00594-1","article-title":"Genomic structures of SCN2A and SCN3A \u2013 candidate genes for deafness at the DFNA16 locus","volume":"264","author":"Kasai","year":"2001","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110297_bb0335","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4161\/chan.26023","article-title":"Correlations in timing of Sodium Channel expression, epilepsy, and sudden death in Dravet syndrome","volume":"7","author":"Cheah","year":"2013","journal-title":"Channels"},{"issue":"43","key":"10.1016\/j.bioorg.2026.110297_bb0340","doi-asserted-by":"crossref","first-page":"33404","DOI":"10.1074\/jbc.M110.114058","article-title":"The Sodium Channel \u03923-subunit induces multiphasic gating in NaV1.3 and affects fast inactivation via distinct intracellular regions","volume":"285","author":"Cusdin","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110297_bb0345","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2019.06.031","article-title":"Resting-state structure and gating mechanism of a voltage-gated sodium channel","volume":"178","author":"Wisedchaisri","year":"2019","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110297_bb0350","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/WNR.0b013e328351db48","article-title":"Upregulated expression of voltage-gated Sodium Channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb","volume":"23","author":"Yu","year":"2012","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110297_bb0355","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1039\/C7MD00131B","article-title":"The discovery of a potent Nav 1.3 inhibitor with good Oral pharmacokinetics","volume":"8","author":"Pryde","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.110297_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115530","article-title":"New aryl and Acylsulfonamides as state-dependent inhibitors of Nav1.3 voltage-gated Sodium Channel","volume":"258","author":"Zidar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110297_bb0365","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.090034797","article-title":"Sodium Channel Na(v)1.6 is localized at nodes of Ranvier, dendrites, and synapses","volume":"97","author":"Caldwell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110297_bb0370","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80969-1","article-title":"Altered subthreshold sodium currents and disrupted firing patterns in Purkinje neurons of Scn8a mutant mice","volume":"19","author":"Raman","year":"1997","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110297_bb0375","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuron.2012.01.007","article-title":"Signal processing in the axon initial segment","volume":"73","author":"Kole","year":"2012","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110297_bb0380","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/cells10071595","article-title":"Distinctive properties and powerful neuromodulation of Nav1.6 sodium channels regulates neuronal excitability","volume":"10","author":"Zybura","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110297_bb0385","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/brain\/awy324","article-title":"Prominent role of forebrain excitatory neurons in SCN8A encephalopathy","volume":"142","author":"Bunton-Stasyshyn","year":"2019","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0390","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/WNL.0000000000001211","article-title":"The phenotypic spectrum of SCN8A encephalopathy","volume":"84","author":"Larsen","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110297_bb0395","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1038\/s41401-022-00955-x","article-title":"SCN8A epileptic encephalopathy mutations display a gain-of-function phenotype and divergent sensitivity to antiepileptic drugs","volume":"43","author":"Guo","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110297_bb0400","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1152\/jn.00383.2013","article-title":"Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during Epileptogenesis","volume":"110","author":"Hargus","year":"2013","journal-title":"J. Neurophysiol."},{"issue":"44","key":"10.1016\/j.bioorg.2026.110297_bb0405","doi-asserted-by":"crossref","first-page":"9257","DOI":"10.1523\/JNEUROSCI.0718-21.2021","article-title":"Somatostatin-positive interneurons contribute to seizures in SCN8A epileptic encephalopathy","volume":"41","author":"Wengert","year":"2021","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.112.198887","article-title":"A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias","volume":"344","author":"Belardinelli","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0415","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/s41598-017-01851-9","article-title":"Unexpected efficacy of a novel Sodium Channel modulator in Dravet syndrome","volume":"7","author":"Anderson","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110297_bb0420","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/epi.12657","article-title":"Antiepileptic activity of preferential inhibitors of persistent sodium current","volume":"55","author":"Anderson","year":"2014","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110297_bb0425","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/epi.14196","article-title":"The novel Sodium Channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy","volume":"59","author":"Baker","year":"2018","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110297_bb0430","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/epi.17149","article-title":"The novel persistent sodium current inhibitor PRAX-562 has potent anticonvulsant activity with improved protective index relative to standard of care Sodium Channel blockers","volume":"63","author":"Kahlig","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.bioorg.2026.110297_bb0435","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72468","article-title":"NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats","volume":"11","author":"Johnson","year":"2022","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110297_bb0440","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/acschemneuro.3c00757","article-title":"Molecular pharmacology of selective NaV 1.6 and dual NaV 1.6\/NaV 1.2 channel inhibitors that suppress excitatory neuronal activity ex vivo","volume":"15","author":"Goodchild","year":"2024","journal-title":"ACS Chem. Neurosci."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110297_bb0445","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1021\/acs.jmedchem.9b01032","article-title":"Identification of CNS-penetrant aryl Sulfonamides as isoform-selective NaV 1.6 inhibitors with efficacy in mouse models of epilepsy","volume":"62","author":"Focken","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110297_bb0450","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.105696","article-title":"Differential roles of NaV1.2 and NaV1.6 in neocortical pyramidal cell excitability","volume":"14","author":"Garcia","year":"2025","journal-title":"Elife"},{"issue":"29","key":"10.1016\/j.bioorg.2026.110297_bb0455","doi-asserted-by":"crossref","first-page":"E2724","DOI":"10.1073\/pnas.1220844110","article-title":"Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels","volume":"110","author":"McCormack","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110297_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.molpha.2025.100072","article-title":"Voltage sensor interaction site for a selective small molecule Nav1.1 Sodium Channel potentiator that enhances firing of fast-spiking interneurons","volume":"107","author":"Gallucci","year":"2025","journal-title":"Mol. Pharmacol."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110297_bb0465","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1016\/j.bmcl.2008.09.036","article-title":"2,4(5)-Diarylimidazoles: synthesis and biological evaluation of a new class of Sodium Channel blockers against hNav1.2","volume":"18","author":"Rivara","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110297_bb0470","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/15701808113109990050","article-title":"Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers","volume":"11","author":"Rivara","year":"2014","journal-title":"Lett. Drug Des. Discov."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:15:07Z","timestamp":1791407707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":94,"alternative-id":["S0045206826008333"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110297","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium ion channels as therapeutic targets in epilepsy: a drug discovery perspective","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110297"}}